An estimated 16 million people in the United States have a formal dry eye disease (DED) diagnosis, yet experts know the condition is notoriously underdiagnosed.
Join Drs. Beckman, Matossian, and Pepose as they share their insight and expertise into the complexities of meibomian gland dysfunction–related DED and the best approach for diagnosing and treating each patient.
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education 
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Kenneth A. Beckman, MD
Director of Corneal Services
Comprehensive Eye Care of Central Ohio
Westerville, OH
Cynthia Matossian, MD, FACS
Founder and Medical Director
Matossian Eye Associates
Doylestown, PA
Hopewell, NJ
Jay S. Pepose, MD, PhD
Director, Pepose Vision Institute
Professor of Clinical Ophthalmology
Washington University School of Medicine
St. Louis, MO
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Kenneth A. Beckman, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Alcon Vision, Allergan, Avellino Labs, Bausch + Lomb, Biotissue, Bruder, Carl Zeiss Meditec, Dompé, Eyepoint, Eyevance, Glaukos, Glint, Johnson & Johnson, Kala Pharmaceuticals, Leo Pharma, Novaliq, Novartis, Ocular Science, Ocular Therapeutix, Omeros, Refocus, Rx Sight, Sun Pharmaceutical Industries, TearLab, Trefoil, and Visus.
Cynthia Matossian, MD, FACS, has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Aramis Biosciences, Bausch + Lomb, Bruder Healthcare, Carl Zeiss Meditec, Checked-Up, Conclusn, Dompé, EyePoint Pharmaceuticals, Eyevance, Glint Pharmaceuticals, Guardion Health Services, Imprimis Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, LacriSciences Vision, legrande Health, Lenstec, lumenis, Marco, MDBackline, MiCare, MYZE, Novartis, NuLids, Ocular Science, Olympic, Omeros, Osmotica Pharmaceuticals, Physician Recommended Nutriceuticals, Quidel, Reger-Eyes, StepWise Medical, Sun Pharmaceutical Industries, TearLab, TearScience, TissueTech, Visionology, and Visus Therapeutics. Grant/Research Support: Dompé, Imprimis Pharmaceuticals, Johnson & Johnson, and Novartis. Speaker's Bureau: Alcon, Allergan, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Eyevance, Guardion Health Services, Imprimis Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, LacriSciences Vision, Lumenis, Novartis, NuLids, Olympic, Omeros, Physician Recommended Nutriceuticals, Sun Pharmaceutical Industries, TearLab, TearScience, and TissueTech. Shareholder: Checked-Up, Physician Recommended Nutriceuticals, and Strathspey Crown.
Jay S. Pepose, MD, PhD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Acufocus, Allergan/AbbVie, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, Mimetogen, Novartis, Ocuphire Pharma, Stuart Therapeutics, Sun Pharmaceutical Industries, and Thea.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
